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Dependence of upper limit of metastability on supersaturation in
nephrolithiasis. Formation of renal stones requires supersaturation (SS)
high enough to induce crystallization; such a SS is referred to as the upper
limit of mctastability (ULM). The ULM for calcium oxalate (CaOx) or
calcium phosphate can be measured by adding oxalate or calcium to urine,
respectively, and noting the point at which overt crystallization occurs as
evidenced by clouding. In principle, the urine should he more prone to
form stone crystals as its SS approaches the ULM, and the SS ULM
distance has been used as an index of stone forming potential. In addition,
one would expect the ULM and initial SS to be unrelated, as the starting
urine SS has no apparent link to the amount of calcium or oxalate that
urine can dissolve without leading to crystal formation. However, in rats,
we have found a surprising correlation between ULM and SS, such that
ULM appears to rise with initial SS, for CaOx, and, to a lesser extent, for
brushite (Br), a typical calcium phosphate initial phase. In this study, we
measured CaOx and Br ULM, and SS, in urine of 50 patients and 11
normal people, to determine if ULM and SS were correlated, as in rats,
and to explore the relationship between SS and ULM. We found the same
dependence of ULM on SS as in rats, for both CaOx and Br, and found no
differences between patients and normal people with respect to this
dependency. However, for Br, patients showed a lower ULM than
normals, but the same initial SS, meaning that patients were closer to their
crystal formation threshold than normals. Treatments for stones had no
apparent effect on the SS-ULM dependency. We conclude that in humans,
as in rats, ULM is related to initial SS, and that this relationship is the
same in patients as in normals for CaOx, but shifted in a stone forming
direction for Br among patients. The ULM-SS interaction is unaffected by
contemporary conventional stone treatments, and is more marked for
CaOx than Br. The mechanisms of the dependence are unknown. The
smaller difference between ULM and initial SS for Br in patients than
normal supports prior evidence suggesting a defect in stone patients that
could lead to calcium phosphate crystallization, subsequent nucleation of
CaOx, and stone disease.
Formation of renal stones requires production of solid phases
such as calcium oxalate (CaOx), calcium phosphate, uric acid,
struvite, and less common crystals [11. Of these, CaOx and calcium
phosphate arc among the most common in human calculi [1]. The
driving force for crystallization is supersaturation (SS), which can
he expressed as the ratio of the concentration of the dissolved salt
divided by the solubility of that salt in urine at body temperature
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[2]. As SS rises in urine, a point is reached at which solid phase
begins to form, and that SS point is usually referred to as the
upper limit of the metastable range (ULM) [3]. Below this limit
SS permits growth of preformed crystals but not their de novo
formation [31.
In principle, stone risk should follow the closeness of the SS of
a urine to the ULM in that urine [4]. Such comparisons have been
usefully performed using an experimental technique for determin-
ing the ULM, in which SS is raised progressively by addition of
oxalate or calcium. As SS rises, the ULM is detected by obser-
vance of cloudiness from crystals [4—6]. When urine pH is fixed at
6.4, sodium oxalate addition results in the eventual crystallization
of CaOx [5, 7], and the SS with respect to CaOx monohydrate at
the crystallization point is called the ULM for CaOx. Adding
calcium chloride at pH 6.4 causes eventual crystallization of
brushite (Br, calcium monohydrogen phosphate) [5], and the
ULM is usually expressed as SS with respect to Br at the
crystallization point.
Using this valuable technology in the analysis of stone forma-
tion in a colony of inbred hypercalciuric rats [81, we established
that high initial Br SS was combined with a Br ULM quite
close to the initial SS. By contrast, the ULM for CaOx was much
higher than the initial CaOx SS. A reasonable basis for the
observed fact that such rats form calcium phosphate stones [9]
could well be the much smaller distance between SS and ULM for
Br versus CaOx. In the course of the work, we noted that ULM for
CaOx and Br seemed related to their initial SS, a fact that was
surprising and not easily explained. The present study was de-
signed to test whether this linkage between ULM and SS could be
found in humans. Accordingly, we measured ULM in normal
people, and in both treated and untreated patients with nephro-
lithiasis.
METHODS
Patients and normals
Fifty-four 24-hour urine samples were collected from 50 pa-
tients (19 women); one man and one woman provided three
pretreatment urines each. The rest each provided one urine
sample. In all, 28 urines were pretreatment, and 26 were during
treatment. Urines were collected unrefrigerated using thymol as a
preservative [10]. Of the 50 stone formers, 39 had calcium stones,
9 had orate stones (8 admixed with calcium), I had cystine stones
and 7 patients had unknown stone types. Metabolic abnormalities
included hypercalciuria in 31 patients, hypocitraturia in 18 pa-
tients, hyperoxaluria in 8 patients, hyperuricosuria in 6 patients,
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Calcium oxalate SS
Fig. 1. Relationship between the upper limit of metastability (ULM) and
supersaturation (SS) for calcium oxalate (CaOx). Among normals (•)
and patients (0), ULM rose with SS. Values for the regression are in the
Results section. All but one point is above the diagonal line of identity,
indicating that ULM exceeds SS by a generous margin. Although the
normal points seem at the low end of the patient distribution, normal
ULM values were not lower even when covariance with SS was considered
(Table I). The general overlap of SS and ULM values for patients and
normals is evident from the dot plots along the horizontal and vertical axes
of the graph.
and cystinuria in one patient. The total for both stone type and
metabolic abnormality exceeded the 50 patients since some
patients had mixed stone types and multiple metabolic problems.
Treatments [11] included hydration and reduced sodium and
oxalate intake, and active medications including thiazide diuretic
agents (4 patients), sodium or potassium citrate or bicarbonate
salt supplements (9 patients), both agents together (12 patients),
and allopurinol alone (1 patient). No patterns of difference
emerged among the kinds of treatments, so treatment urines are
pooled for analysis. Patients were unselected except for being the
consecutive new and follow-up patients over a four month period.
Eleven normal people (2 women) each provided one 24-hour
collection.
Routine laboratory measurements including supersaturation
Calcium, chloride, creatinine, magnesium, sodium, potassium,
phosphate, ammonium, and uric acid concentrations were mea-
sured in each urine by standard laboratory techniques (Beckman
Synchron CX5; Beckman Instruments, Brea, CA, USA). pH was
measured by glass electrode. Sulfate was measured by barium
precipitation [12]. Oxalate was measured by enzyme assay using
oxalate oxidase (Sigma Corp., St. Louis, MO, USA). Citrate was
measured by enzyme assay using citrate lyase (Mannheim Bohr-
inger, Mannheim Germany). From this array, we calculated the
SS with respect to CaOx and Br using the relative saturation ratio
from EQUIL2, an iterative computer program [2].
Table 1. Supersaturation (SS) and upper limit of metastability (ULM)
values in patients and normals
Normals Patients
(11) (54)
Unadjusted Adjusted Unadjusted Adjusted
SS CaOx 8 1 6.6 0.7
ULMCaOx 24±3 22±2 24±2 24±1
SS Br 1.4 0.4 1.4 0.2
ULM Br 5.7 0.6 5.7 0.5 4 0.2° 3.9 0.2"
Differs from normal, "P < 0.05 "P < 0.001
Abbreviations are: unadjusted and adjusted refer to covariance with
corresponding SS; SS, supersaturation; CaOx, calcium oxalate; Br, brush-
ite a specific calcium phosphate phase (Methods); ULM, the value of SS
at the point of visible crystal formation (Methods). All values are means
SEM.
Statistical analysis
Means and SD, t-tests, analysis of covariance, and interactive
stepwise logistic regression were performed using standard statis-
tical software (SYSTAT 6.0; SPSS Corp., Chicago, IL, USA).
RESULTS
Calcium oxalate ULM was highly correlated with CaOx SS (Fig.
1) among patients and normals (r = 0.619, P < 0.001). All but a
few points rested far above the line of identity (diagonal line on
the figure), showing the wide margin between SS and the ULM.
This margin appears slightly lower in our normals than patients
(compare closed to open symbols), but mean values for ULM in
patients and normals did not differ significantly even when
covariance with SS was accounted for (Table 1). If only the
calcium stone formers are compared to normals, there was still no
difference in CaOx ULM (24.1 vs. 23.6, P = 0.904). Among only
patients, the relationship between ULM and SS remained strong
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Upper limit of metastability
5 10 15 20 A modification of the method described by Nicar, Hill and Pak
[5] was used to determine the ULM of CaOx and Br in human
urine as previously described from this laboratory [8]. An aliquot
of urine from a 24-hour urine collection was centrifuged for 30
minutes at 3000 RPM to remove debris. Urine pH was adjusted to
6.4 by addition of HCI or NaOH as required. Ten milliliters of
each urine sample were placed into each of 13 tubes, and sodium
azide was added to each tube, at a final concentration of 0.02%, to
prevent bacterial growth. The tubes were placed in a water bath at
37°C and magnetically stirred. To initiate CaOx precipitation,
increasing amounts of sodium oxalate were added to each set of
tubes. One tube had no oxalate added to serve as blank. The pH
of each tube was checked hourly during the incubation and acid or
alkali added as required to maintain pH at 6.4. After three hours
the samples were checked for visible precipitation; the tube with
the lowest amount of oxalate added that initiated crystallization
was considered the endpoint. The SS at the point of precipitation
was calculated using EQUIL, assuming all chemical concentra-
tions were unchanged except for oxalate, which was taken as the
initial measured oxalate concentration plus the amount added to
the tube. Brushite ULM was determined in the same fashion,
except calcium chloride was added to the urine samples to
precipitate Br [5].
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Untreated Treated
(28) (26)
Unadjusted Adjusted Unadjusted Adjusted
SS CaOx 7.6 .7 5.4 0.7'
IJLM CaOx 27 2 26 1 21 1 22 1
SS Br 1.33 0.2 1.46 0.2
ULM Br 4.2 0.3 4.24 0.26C 3.7 0.3 3.7 0.27
Abbreviations are in Table 1.
Note that no comparisons were made between treated patients and
normals.
Differs from untreated, up < 0.05 h< 0.01; C, differs from normal, P <
0.02
(Fig. 2) and uninfluenced (Table 2) by treatment versus pretreat-
ment status (compare open vs. closed symbols). The regression of
ULM on SS using only normal and pretreatment data from
patients was also highly significant (r = 0.625, P < 0.001). Using
only data from patients, the r and P values for pretreatment and
treatment respectively were 0.44 and 0.018 versus 0.53 and 0.005.
Urine collected during treatment had a lower CaOx SS than those
collected pretreatment (Table 2); the comparison was between
the treatment and pretreatment patient groups, not between
treatment and pretreatment in individual patients. We did not
compare treatment patient data to normal data, because the
comparison seemed, to us, inappropriate.
For Br, ULM was correlated less dramatically with SS than was
the case for CaOx (Fig. 3); however, the regression was statisti-
cally significant (r 0.340, P = 0.005). Normals (closed symbols)
had higher ULM values than patients, as shown by their position
Brushite SS
Fig. 3. Relationship between the upper limit of metastability (ULM) and
supersaturation (SS) for brushite (Br). Among normals (•) and patients(0), ULM rose with SS. Values for the regression are in the Results
section. Normal people have higher ULM values than patients, even when
covariance with SS is considered (Table 1). This is best visualized using the
univariate plot of ULM along the right axis of the graph. ULM exceeds SS
among patients by a lesser amount than among normals.
in Figure 3, and by both direct t-tests, and analysis of covariance
(Table 1). Comparing only the calcium stone formers to the
normals we found a significantly lower ULM for the stone formers
(3.9 vs. 5.7, P = 0.027), but there was not a difference between the
calcium stone formers and the stone forming group as a whole.
Treatment status had no apparent effect on the relationship
between ULM and SS (Fig. 4 and Table 2), even though the
regression of ULM on SS using only normal and pretreatment
data from patients was marginal (r = 0.301, P = 0.058). Regres-
sion coefficients (r) and P values for pre-treatment and treatment
were 0.405, P = 0.033 and 0.538, P = 0.005, respectively. Using
only pretreatment results, ULM no longer differed significantly
from normal, but this was due mainly to the reduced sample size,
as the difference of means was the same (Tables 1 and 2).
Treatment ULM for Br (Table 2) was lower than pretreatment,
but not significantly. Using SS as covariate, ULM also did not
change significantly between treatment and pretreatment, but
ULM Br was lower in patients than in normals (Table 2 vs. Table
1, adjusted ULM values). Brushite SS did not change significantly
with treatment.
The ULM is correlated not only with SS, but also with other
urine measurements (Table 3). Common to both CaOx and Br
ULM were both the CaOx and Br SS values, and urine calcium
and citrate concentrations. Urine pH, oxalate, and phosphorus
concentrations were correlated with ULM for Br, hut not for
CaOx. These many correlations are difficult to make sense of
because urine concentrations are themselves volume dependent,
in part, and therefore correlated with each other and with SS
itself. To clarify the independent covariates of ULM, we used
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Calcium oxalate SS
Fig. 2. Relationship between the upper limit of metastability (ULM) and
supersaturation (SS) for calcium oxalate (CaOx) among treated (•) and
untreated (0) patients. The ULM and SS were correlated, and occupied
the same ranges (Table 2). Their intermixture is best visualized using the
univariate plots along the axes of the graph.
Table 2. Supersaturation (SS) and upper limit of metastability (ULM)
values in treated and untreated patients
5 10 15 20 0 2 4 6 8
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Brushite SS
Fig. 4. Relationship between the upper limit of metastability (ULM) and
supersaturation (SS) for brushite (Br) in treated (•) and untreated (0)
patients. The modest and statistically insignificant effects of treatment on
both variables can be visualized using the univariate plots along the axes
of the graph. Without treatment, ULM is below normal (compare to Fig.
3, Table 2 to Table 1).
SS CaOx 0.619 0.000 0.639 0.000
SS Br 0.259 0.037 0.340 0.005
Calcium 0.595 0.000 0.654 0.000
Citrate 0.398 0.000 0.434 0.000
pH —0.22 NS —0.57 0.000
Oxalate 0.197 NS 0.571 0.000
Phosphorus 0.224 NS 0.774 0.000
Sodium 0.16 NS 0.38 0.002
Potassium 0.011 NS 0.42 0.0004
Values of P are for the individual measurements, r, the regression
coefficient.
Abbreviations are in Table I.
Table 4. Multivariate correlation of the upper limit of metastability
(ULM) on urine measurements
ULM CaOx r P ULM Br r P
SS CaOx 0.625 0.000 Phosphorous 0.723 0.000
Oxalate 0.735 0.0014 Citrate 0.782 0.0061
Citrate 0.796 0.0044 pH 0.811 0.032
Regression was performed using pretreatment values from patients and
the 11 normals as a pool. Values of r are cumulative as each new term
enters; P values are for the partial correlation of the measurement with
ULM in the final ensemble of three measurements in the total regression.
All measurements were in mg/dl, except pH and SS which are unitless. For
ULM Br, a slightly better overall regression (r = 0.825) could be obtained
with SS Br in place of phosphorus. Coefficients for the final CaOx
regression were 2.08 0.26, 0.12 0.04, and —5.48 1.1 for SS CaOx,
urine citrate, and urine oxalate (latter two in mg/dl), respectively. For
ULM Br, coefficients were 0.032 0.006, 0.02 0.007 and —0.737
0.332 for urine phosphorus and citrate concentrations (in mg/dl), and pH,
respectively.
Urine phosphorus, mg/dI
Fig. 5. Relationship between brushite (Br) upper limit of metastability
(ULM) and urine phosphorus concentration. Among pre-treatment pa-
tients (0) and normals (•) the ULM (y axis) varied smoothly with urine
phosphorus concentration (x axis). The line of linear regression is shown
(r = 0.774, P < 0.001, Table 3; multivariate values in Table 4).
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Table 3. Univariate correlations with the upper limit of metastability
(ULM)
-J
Cl)
Cl)
ULM CaOx ULM Br
12
10
8
6
4
2
0
P r P
0 50 100 150
interactive stepwise logistic regression, with forward stepping. For
CaOx ULM (Table 4), CaOx SS and urine oxalate and citrate
concentrations were the independent covariates, whether we
considered all patient samples and normals, or normals with only
pretreatment patient samples. Urine volume itself had no inde-
pendent effects in the multivariate analysis.
For ULM Br, urine phosphorus and citrate concentrations, and
urine pH were the independent correlates when all samples were
considered. When only pretreatment patient samples and normals
were considered, equivalent fits were obtained with either urine
phosphorus concentration (as in Table 4) or with SS Br in place of
urine phosphorus concentration, along with urine citrate and pH.
Our study offers no direct information concerning possible meeh-
anisms of linkage between ULM and SS or other urine measure-
ments; however, the phosphorus correlation is extraordinary (Fig.
5), suggesting it may well be of critical importance.
Since CaOx SS is strongly dependent upon urine oxalate
concentration, the independent effect of urine oxalate concentra-
tion itself upon ULM CaOx (Table 4), along with SS, suggests that
urine oxalate concentration is somehow itself able to influence
ULM apart from SS. The same is true for urine citrate concen-
tration. The nature of the oxalate effect is a reduction of ULM for
a given CaOx SS, that creates a significant fraction of the scatter
in Figure 1 (Fig. 6). Here, the plot of Figure 1 is reproduced,
except that the size of each symbol is scaled to urine oxalate
concentration and the line of identity is replaced by a power
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o o o •, • 0 begins with another solid phase, perhaps a calcium phosphate. Weto 00 0
mightpresume that CaOx is prevalent because it is stable at all pH
0 values urine can attain, whereas the calcium phosphate phases are
not stable at pH values much below 6 [131.
0 Normal people do not have higher CaOx ULM values than
patients, and treated patients are no higher than untreated.
•
However, Br ULM values are higher in normals than patients, as
is evident statistically and by inspection of Figure 3. This discrep-
ancy arises from unknown sources, but suggests some possible
.. defect in a normal protective system among patients that would
lead to Br crystallization. Given the large body of evidence that
calcium phosphate crystal can be an efficient heterogeneous
nuclei for CaOx [14—17], and that Br is an early nucleating phase
in a sequence that eventuates in apatite [7, 18, 19], it is possible
that the lower ULM for Br might be important in producing CaOx
stones. In this case, the lack of a reduced CaOx ULM in patients
• may well reflect Br or another calcium phosphate phase acting as
a nucleator for CaOx. Therefore, CaOx would not have to achieve
its own ULM in urine in order to become a stone solid phase.
10 15 20 Using the same experimental technique, but a different ap-
proach to calculation, Pak and Holt [6] found reduced Br ULM in
patients versus normals, accompanied by higher Br SS in patients.
The correspondence of our Br ULM results with theirs add
confidence that both are correct. Pak and Galosy [4] also report
reduced ULM for Br using many groups of patients with ncphro-
lithiasis. By contrast, both prior studies find lower CaOx ULM
among patients than normals, whereas we did not. Moreover, the
strong positive correlation we find between SS and ULM is
contrasted to the low CaOx SS and high ULM they found in
normals versus patients. That we agree in one and not the other
solid phase is unexplained at this time. Differences in patient
groups cannot be excluded.
The possible mechanisms linking ULM and SS are unclear, but
several remarkable correlations suggest possible avenues for
subsequent exploration. ULM for CaOx is clearly inversely related
to urine oxalate concentration at any level of CaOx SS, even
though urine oxalate is itself a major component of CaOx SS and
CaOx SS is strongly and directly proportional to urine oxalate
concentration. Perhaps the usual high calcium to oxalate ratio of
urine (typical values are 2 to 8 mM for calcium and 0.2 to 0.5 mM
for oxalate) [13] reduces crystallization and a higher urine oxalate,
by bringing the ratio closer to equimolarity, fosters nucleation,
lowering the ULM. Unbalanced stoichiometry could possibly
explain the strong and independent proportional relationship
between CaOx ULM and SS CaOx. If we plot the ULM against
the ratio of calcium to oxalate molarity (Fig. 7) high and low SS
points, indicated by size variation, scatter on both sides of the
linear regression line. However, SS, ULM, the calcium:oxalate
ratio, and oxalate molarity all are strongly interrelated, so statis-
tical inferences are very tenuous. For example, if SS CaOx is taken
in stepwise regression as a correlate of ULM CaOx, the calcium to
oxalate molar ratio remains highly significant (F = 6, P < 0.01),
but oxalate molarity is more so (F 12, P < 0.001); if oxalate
molarity is also taken as a second covariate with ULM, the ratio
loses all significance (F = 0.2, P = 0.655). In other words, new
experiments must elucidate the matters that our analysis can only
suggest may be important.
Brushite ULM is related most strongly to urine phosphorus
concentration (Fig. 5). Perhaps urine pyrophosphate, which varies
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Fig. 6. Interaction between the upper limit of metastability (ULM),
calcium oxalate (CaOx) supersaturation (SS), and urine oxalate concen-
tration. The ULM (y axis) varies with SS (X axis) as in Figure 1; the
powered regression line (yaxh) is shown here instead of the line of identity
of Figure 1, otherwise the 26 treatment urines (•) and results from 28
pretreatment samples and 11 normal samples (0) are identical to Figure
1. Symbol size is proportioned to urine oxalate Concentration. Note the
striking preponderance of large symbols below the regression line, which
graphically depicts the negative correlation of ULM on urine oxalate
concentration (Table 4).
0 5
function regression line. The lower ULM points, which lie below
the regression line, contain the majority of large symbols, which
depict higher urine oxalate concentrations. These are evenly
distributed between treatment (light fill) and pretreatment and
normal samples (dark fill). If a similar plot is made using citrate
concentration, higher values lie above the regression, but to a
lesser extent, however (not shown).
DISCUSSION
The apparent linking of ULM to SS for both CaOx and Br is
surprising, and rather difficult to explain. That it occurs in rats [8]
and humans, and in normals and patients, treated and untreated
alike suggests that it is an important phenomenon. It is not likely
to be due to an in vitro artifact as we used a well established
method to find values for ULM not very different from those
described by other researchers [5]. In simple salt systems, the
point of crystallization has no relationship to the arbitrary starting
SS of the fluid; whatever the initial SS, provided it is below the
ULM, one simply raises the SS to the ULM.
The linkage phenomenon is more obvious for CaOx than Br,
though statistically both show strong regressions of ULM on SS.
The larger gap between the SS and the ULM, for CaOx versus Br,
observed by others in humans [4] and by us in rats [8] makes CaOx
seem less likely to form, even though CaOx is certainly the most
prevalent stone salt in humans. It may be that CaOx is not the
most common or important initial solid phase, hut a very stable
phase that occurs as part of a cascade of nucleation events that
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relevant solid phases, and some other phase, probably a poorly
formed apatite [261 has a ULM near to average SS, which is easily
exceeded. Perhaps seed crystals form in a part of the nephron
whose SS is not reflected in the final urine, and these nucleate
CaOx, in a cascade. We have in fact proposed such SS in the thin
limb of the loop of Henle [26]. About the latter, we are reasonably
confident that the universal SS of urine with CaOx reflects kinetic
retardation by urine molecules [15]. Crystals certainly are present
in urine of stone formers and many normals [31, so without such
retardants ions would be depleted over hours to a few days [3].
With them, the process is delayed by 10- to 100-fold, and urines
collected and processed within a few days will show stable SS
values.
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Calcium/Oxalate
Fig. 7. Interaction between the upper limit of metastability (ULM)
calcium oxalate (CaOx) and the molar calcium to oxalate concentration
ratio. The ULM varied strongly with the ratio (x axis), as it did with CaOx
SS; however, the ULM values for samples with high CaOx SS (large
symbols) scattered symmetrically about the linear best fit regression,
compatible with the assumption that the correlation between ULM and
CaOx SS was due in significant measure to variation of the molar ratio.
proportionately to urine total phosphorus concentration, is im-
portant in elevating the Br ULM [20, 21]. This in turn may explain
the relationship between SS Br and ULM Br, since SS Br is
directly and strongly related to urine phosphorus concentration.
As well, other inhibitors, large or small molecules, could play an
as yet unspecified role.
The clinical relevance of this study is as yet unexplored, but has
considerable potential. Perhaps the relationship between ULM
and SS is a determining feature of stones, as others have suggested
[4—7, 22—25]. Of note, prior workers [4—7] did not find any
dependence of ULM on SS for either CaOx or Br. However, when
urine volume and calcium intake are not controlled, as they were
in prior studies [4—7], and the ranges of SS and perhaps the molar
calcium to oxalate ratio are allowed to become large, as in this
study, ULM varies with SS, most markedly for CaOx. Defects in
patients could reside not only in the difference between ULM and
SS, but in the response of ULM to SS, especially for CaOx. For Br,
the correspondence of prior clinical studies with this one, and with
studies in hypercalciuric rats, makes a low ULM for Br seem
rather characteristic of both calcium phosphate stone forming rats
and humans who make predominantly CaOx stones. The preva-
lence of this apparent defect seems high, and patients with it may
turn out to have hitherto unsuspected defects in other aspects of
urine chemistry or inhibitor molecules.
Finally, our study may prompt some to ask how crystals form in
the first place, given ULM values above SS in almost all samples
and—perhaps even more fundamentally—if crystals are present in
urine, how SS is maintained. About the former, we can only
speculate. Perhaps spikes of SS, averaged out by 24 hour collec-
tions, are not accompanied by corresponding ULM, and permit
nucleation. It may well be that Br and CaOx are not the only
Reprint requests to Fredric L. Coe, M.D., Nephrologt Program, University
of Chicago, MC 5100, 5841 S. Maryland Avenue, Chicago, Illinois 60637,
USA.
APPENDIX
Abbreviations used in this article are: SS, supersaturation; ULM, upper
limit of metastability; CaOx, calcium oxalate; Br, brushite.
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